These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8138919)
1. Pharmacokinetics of 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rats. Abobo CV; Ni L; Schinazi RF; Liotta DC; Boudinot FD J Pharm Sci; 1994 Jan; 83(1):96-9. PubMed ID: 8138919 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus. Frick LW; St John L; Taylor LC; Painter GR; Furman PA; Liotta DC; Furfine ES; Nelson DJ Antimicrob Agents Chemother; 1993 Nov; 37(11):2285-92. PubMed ID: 8285607 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and metabolism of racemic 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rhesus monkeys. Schinazi RF; Boudinot FD; Ibrahim SS; Manning C; McClure HM; Liotta DC Antimicrob Agents Chemother; 1992 Nov; 36(11):2432-8. PubMed ID: 1336946 [TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics of Racivir, (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine in rats, rabbits, dogs, monkeys and HIV-infected humans. Hurwitz SJ; Otto MJ; Schinazi RF Antivir Chem Chemother; 2005; 16(2):117-27. PubMed ID: 15889534 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 1-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-methyluracil (L-FMAU) in rats. Wright JD; Ma T; Chu CK; Boudinot FD Pharm Res; 1995 Sep; 12(9):1350-3. PubMed ID: 8570534 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of the antiviral agent beta-D-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys. Ma L; Hurwitz SJ; Shi J; Mcatee JJ; Liotta DC; McClure HM; Schinazi RF Antimicrob Agents Chemother; 1999 Feb; 43(2):381-4. PubMed ID: 9925539 [TBL] [Abstract][Full Text] [Related]
8. Lack of pharmacokinetic interaction between dipyridamole and zalcitabine in rats. Abobo CV; Xian Y Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1045-50. PubMed ID: 9449537 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus. Frick LW; Lambe CU; St John L; Taylor LC; Nelson DJ Antimicrob Agents Chemother; 1994 Dec; 38(12):2722-9. PubMed ID: 7695253 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of 2',3'-dideoxycytidine in rats: application to interspecies scale-up. Ibrahim SS; Boudinot FD J Pharm Pharmacol; 1989 Dec; 41(12):829-34. PubMed ID: 2576444 [TBL] [Abstract][Full Text] [Related]
11. Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity. Cui L; Schinazi RF; Gosselin G; Imbach JL; Chu CK; Rando RF; Revankar GR; Sommadossi JP Biochem Pharmacol; 1996 Nov; 52(10):1577-84. PubMed ID: 8937473 [TBL] [Abstract][Full Text] [Related]
12. Intracellular metabolism of (-)- and (+)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in HepG2 derivative 2.2.15 (subclone P5A) cells. Paff MT; Averett DR; Prus KL; Miller WH; Nelson DJ Antimicrob Agents Chemother; 1994 Jun; 38(6):1230-8. PubMed ID: 8092819 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of 2',3'-dideoxycytidine after high-dose administration to rats. Ibrahim SS; Boudinot FD J Pharm Sci; 1991 Jan; 80(1):36-8. PubMed ID: 1849573 [TBL] [Abstract][Full Text] [Related]
14. Interspecies scaling and pharmacokinetic parameters of 3TC in humans. Hussey EK; Donn KH; Daniel MJ; Hall ST; Harker AJ; Evans GL J Clin Pharmacol; 1994 Oct; 34(10):975-7. PubMed ID: 7530728 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys. Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248 [TBL] [Abstract][Full Text] [Related]
17. Preclinical pharmacokinetics of beta-L-dioxolane-cytidine, a novel anticancer agent, in rats. Moore LE; Boudinot FD; Chu CK Cancer Chemother Pharmacol; 1997; 39(6):532-6. PubMed ID: 9118465 [TBL] [Abstract][Full Text] [Related]